1. HHS has distributed the Provider Relief Fund to Medicare provider since April 10, 2020 via direct deposit or paper check. Read more, here.
2. Providers can request for reimbursement for testing and treating uninsured patients due to COVID-19 since February 4, 2020. Portal opened on April 27, 2020. Read more, here. Apply today!

• It is under the CARES Act. For more information, click here.
• Payment is based on your Medicare FFS claims in 2019. Payments are given to eligible providers.
• This is not a loan; no need to payback.
• You may receive this payment via Optum Bank with "HHSPAYMENT" as the payment description through direct deposit or a paper check in a few weeks.
• Providers must agree not to seek collection of out-of-pocket payments from a COVID-19 patient that are greater than what the patient would have otherwise been required to pay if the care had been provided by an in-network provider.
• You may accept or reject the payment.
• Within 30 days of receiving this payment, providers must sign an attestation confirming receipt of the funds and agreeing to the terms and conditions of payment. Attest, click here.
• Terms and Conditions - PDF
• For additional information, recipients should visit http://hhs.gov/providerrelief or call the CARES Provider Relief line at (866) 569-3522.
• There are no details about Medicaid provider funding distribution yet.

• Enroll as a provider participant (starting today, here)
• Check patient eligibility and benefits
• Submit patient information
• Submit claims starting May 6, 2020
• Receive payment via direct deposit

• You have checked for health care coverage eligibility and confirmed that the patient is uninsured. You have verified that the patient does not have coverage such as individual, employer-sponsored, Medicare or Medicaid coverage, and no other payer will reimburse you for COVID-19 testing and/or care for that patient
• You will accept defined program reimbursement as payment in full.
• You agree not to balance bill the patient.
• You agree to program terms and conditions and may be subject to post-reimbursement audit review.

• April 22 – Program Details launch
• April 27 – Sign up period begins for the program
• April 29 – On Demand training starts
• May 6 – Begin submitting claims electronically
• Mid-May – Begin receiving reimbursement

• Specimen collection, diagnostic and antibody testing.
• Testing-related visits including in the following settings: office, urgent care or emergency room or via telehealth.
• Treatment, including office visit (including via telehealth), emergency room, inpatient, outpatient/observation, skilled nursing facility, long-term acute care (LTAC), acute inpatient rehab, home health, DME (e.g., oxygen, ventilator), emergency ground ambulance transportation, non-emergent patient transfers via ground ambulance, and FDA approved drugs as they become available for COVID-19 treatment and administered as part of an inpatient stay.
• FDA-approved vaccine, when available.
• For inpatient claims, date of admittance must be on or after February 4, 2020.

• Any treatment without a COVID-19 primary diagnosis, except for pregnancy when the COVID-19 code may be listed as secondary.
• Hospice services.
• Outpatient prescription drugs.

• Reimbursement will be based on current year Medicare fee schedule rates except where otherwise noted.
• Reimbursement will be based on incurred date of service.
• Publication of new codes and updates to existing codes will be made in accordance with CMS.
• For any new codes where a CMS published rate does not exist, claims will be held until CMS publishes corresponding reimbursement information.